By Dietrich Knauth NEW YORK, May 1 (Reuters) - Purdue Pharma said on Friday that it has ceased operations and concluded its ...
May 1 marks the first payment of billions to try to address ongoing harms from the overdose crisis.
Purdue Pharma secured court approval for a $125 million settlement with McKinsey & Co. to resolve claims related to the ...
Shutting down Purdue Pharma and replacing it with the nonprofit Knoa Pharma was perhaps the most innovative aspect of ...
A federal judge criminally sentenced OxyContin-maker Purdue Pharma over its role in the opioid crisis, ahead of upcoming ...
NEW YORK (Reuters) - OxyContin maker Purdue Pharma may proceed with a bankruptcy settlement that protects its Sackler family owners from lawsuits, despite a potential U.S. Supreme Court appeal in the ...
Nearly 140,000 people filed claims against the company for the harm they said its drugs caused. Fewer than half of them will get any compensation.